Completely agree @hooptydog. Right business, right management, right time. + no immediate competitors!?!
Some presentation notes:
Miya is a completely de-risked, disruptive and unique tech: “We have created the world’s first real time intelligent design support system.” (7.20min).
Miya will be an extremely low cost, rapidly deployable solution (high initial cost for each unique hospital deployment/writing of program adaptions; but virtually no set-up costs for future roll-outs in similar settings).
Competitive advantage: there appear to be very few (if any) direct competitors in the space. Mainly large companies ($10B+ revenue p.a.) offering mono-lithic solutions (<$100m/project).
US government mandate to automate 100% of hospitals by 2027. Currently only 4.7% compliance. Approx. 7600 hospitals still to upgrade.
Our current Market Share across Australia is approximately 1.5% and New Zealand 3.6%.
2022 market leader (30% share) in each of these markets would do it for me. And maybe 5% of the US market (400 installations) wouldn’t be too much to ask?
